Subscribe to Newsletter

Shigeru Kinoshita

The Power List 2018

Shigeru Kinoshita

Professor and Chair of Frontier Medical Science and Technology for Ophthalmology, at Kyoto Prefectural University of Medicine, Kyoto, Japan

Shigeru Kinoshita established, along with Richard Thoft, the concept of centripetal movement of corneal epithelium. This shed new light on the importance of the limbal epithelium and contributed to the development of corneal stem cell theory. Kinoshita’s group recently established systems to transplant cultivated mucosal epithelial stem cells and cultivated corneal endothelium.

What have been your career highlights?

“I have been pursuing the new modalities for corneal and ocular surface disorders.”

What are your goals for the future?

“I would like to establish the cultured corneal endothelial cell injection therapy for bullous keratopathy, and to try to educate young, energetic clinician-scientists.”

What has been your most successful collaboration?

“There have been many successful collaborations with universities and institutes in USA, EU and Asia. Thus, it is difficult to select one for the best.”

What drives you day-to-day?

“Intellectual curiosity.”

Who have been your mentors?

“Richard A Thoft, Wayne Streilein, and Reizo Manabe.”

Looking Beneath the Surface


Part of the Power List 2018

100 reasons to be proud

This is the third time we have tried to map the Top 100 most influential people in the world of ophthalmology. The list includes surgeons, scientists, engineers, CEOs and more, and each one of them has been voted for by you, our readers.

Go to The Power List 2018

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine



The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: